Casdin Partners Master Fund, L.P.
10% owner, BioLife Solutions; Director, 10% owner, GeneDx Holdings Corp.; Director, 10% owner, Standard Biotools Inc.
Bought, 12 months
$22.6M
Sold, 12 months
$28.1M
Companies
3
Latest trade
May 21, 2026
Companies
BioLife Solutions10% owner −$28.1M GeneDx Holdings Corp.Director, 10% owner +$21.5M Standard Biotools Inc.Director, 10% owner +$1.1MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.


